Skip to main content
. 2022 Apr 2;6(8):1870–1880. doi: 10.1002/hep4.1951

FIGURE 1.

FIGURE 1

Designs of the REP 301 and REP 301‐LTF studies (top) and the REP 401 study (bottom). CTL, control; EXP, experimental; NAP, nucleic acid polymer; pgIFN, pegylated interferon; TDF, tenofovir disoproxil fumarate